Articles Archives - Page 239 of 776

MondayFeb 27, 2023 9:45 am

Data443 Risk Mitigation Inc. (ATDS) Well Positioned Amid Growing Concerns About Cyber Security and Data Protection Practices

A fast-moving ransomware strike recently infected servers made by California-based cloud computing giant, VMWare, leveraging known vulnerabilities previously disclosed by this software company Ransomware continues to be one of the top digital threats and the problem is exacerbated by poor cybersecurity practices, such as lapses in adequate vulnerability management The attack is the last in a series of reminders that businesses need reliable cybersecurity systems and practices provided by companies like Data443 Risk Mitigation to combat malicious attacks instigated by cybercrime perpetrators Cybercriminals are striking again, reminding the public that they are quick to detect and take advantage of any…

MondayFeb 27, 2023 9:00 am

Freight Technologies Inc. (NASDAQ: FRGT) Jumps Revenue Guidance for 2023 Amid New Optimism for Commercial Truck Transport, Tracking Tools

B2B marketplace builder Freight Technologies Inc. is an innovator in resources for strengthening commercial supply chain transports between the United States, Canada and Mexico Freight Technologies, also known as Fr8Tech, has developed its AI-powered Fr8App resource to provide shippers and carriers with the tools they need for monitoring shipments and vehicle performance, and improving efficiency In this month’s State of the Union address, President Joe Biden restated his administration’s commitment to boosting manufacturing close to home through policies that sustain price competitiveness and respect for quality employment Amid optimism for U.S. trade and labor policies, Fr8Tech recently announced revenue projections…

FridayFeb 24, 2023 11:15 am

Web3 Toronto To Explore The World Of Metaverse and Blockchain

The Web3 Toronto Summit, which will be held from March 1-2, 2023, invites entrepreneurs, investors, professionals, collaborators, and enthusiasts of the Metaverse, blockchain and Web3 spectrum, to participate in a robust networking and business opportunity for the Web3 community in Canada and beyond. With Web3 and other evolving technologies growing by leaps and bounds, the Web 3 Toronto Summit will serve as a meaningful initiative of uniting these industries at a common forum. Enthusiasts, traders, and entrepreneurs from all over the world will gather for an unforgettable opportunity of learning and networking through immersive events, experiences, parties, conferences, pitching rooms,…

FridayFeb 24, 2023 10:30 am

GeoSolar Technologies Inc. Set to Benefit from the DOE’s Investments in Geothermal Energy

The Department of Energy recently agreed on a $74 million funding initiative aimed at 7 pilot projects exploring different methods of harnessing geothermal energy Geothermal energy currently generates 3.7 billion kilowatts per annum of electricity in the United States – enough to power 2.5 million homes GeoSolar Technologies has been an early mover within the geothermal technology space, using the renewable energy source as the foundation of its revolutionary SmartGreen(TM) Home system Around 2,900 kilometers (1,800 miles) beneath the Earth’s surface lies the hottest part of our planet – the core. A small portion of the core’s heat, which can…

FridayFeb 24, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) and Its Collaborators Are Positioned to Rapidly Develop COVID-19 Treatments to Neutralize Emerging Variants

BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company primarily targets infectious diseases and autoimmune diseases, with its lead candidate, an inhaled COVID-19 NanoAb therapy, the subject of preclinical studies So far, the preclinical studies have shown that the NanoAb results in significantly milder illness and faster recovery, eliminates the SARS-CoV-2 virus from the lungs, and prevents illness when administered prophylactically The FDA has revoked the authorization of multiple mAb treatments and one mAb prophylactic drug, creating a significant gap in a market that has shown strong demand for COVID-19 treatments BiondVax is…

FridayFeb 24, 2023 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Customer Engagements and Cross-Platform Product Enhancements During Qubits 2023 Convention

D-Wave’s Qubits annual user conference, currently in its seventh year, is one of the industry’s premier quantum computing events differentiated by its focus on real-world applications of quantum technology The company displayed its continued commercial customer momentum and real-time product innovation, reflecting the increasing enterprise adoption of quantum computing solutions The conference demonstrated how D-Wave’s proprietary technology helps organizations solve highly complex business problems today D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing…

ThursdayFeb 23, 2023 12:00 pm

DX3 Canada – The Retail, Marketing And Technology Summit of 2023

DX3 is a leading event management enterprise, organizing summits and trade shows that unite retail, marketing, and technology professionals, leaders, and businesses, on a single floor. They strive to bring meaningful and informative content under one roof, offering a learning and networking opportunity to these industries for better expansion and growth. The experts offer industry insights and gather innovation solutions from international speakers as they conduct discussions, workshops, and meetings at the DX3 Canada 2023 Summit. Be a part of the panel discussions, witness tech demonstrations, and participate virtually in hybrid exhibitions to learn the most advanced and sophisticated skills…

ThursdayFeb 23, 2023 11:15 am

SideChannel Inc. (SDCH) Reports 48% Year-over-Year Revenue Growth in Q1 2023 Amid Continued Progress in Building vCISO Relationships with Clients and an Increase in Products and Services

SideChannel recently released its financial results for Q1 2023, recognizing $1,546,000 in revenue, a 48% year-over-year increase The company also ended the fiscal quarter with $2,553,000 in cash, having spent about $480,000 to offset R&D and marketing expenses SideChannel is in the business of providing cybersecurity leadership and program development through its team of virtual Chief Information Security Officers (“vCISOs”) The company has also developed Enclave, a micro-segmentation software that recently received FIPS 140 certification, opening the door for SideChannel to pursue federal and state contracts and further increase cybersecurity revenue SideChannel (OTCQB: SDCH), a company focused on delivering cybersecurity…

ThursdayFeb 23, 2023 10:30 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) CEO Joins Investor Webinar, Details Corporate Expansion Plans

EverGen Infrastructure CEO, Chase Edgelow recently joined a webinar hosted by Adelaide Capital to provide investors and stakeholders with an update on the company’s operations Edgelow elaborated on the company’s portfolio, including its 4 existing revenue generating assets, 2 projects currently under construction as well as its Ontario-based Greenfield project, Project Radius By 2Q 2023, EverGen anticipated that the completion of its RNG projects would drive gross generating capacity to 240,000 GJ/annum, whilst growing EBITDA by $5-7m per year In the longer term, successful execution on EverGen’s Ontario-based Greenfield project could see the company expand its RNG production by as…

ThursdayFeb 23, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes studies; complete dosing in the human nicotine study NIC-H21-1; and submit and publish additional results in research journals Lexaria’s DehydraTECH technology currently has 28 granted patents, with many more pending patents in countries worldwide Lexaria…

Site Search

Company Search

Category: Articles